Seminars in Oncology

Papers
(The TQCC of Seminars in Oncology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
TOC66
TOC49
Masthead39
PARP inhibitors for prostate cancer26
Incidence of COVID-19 in outpatients with cancer receiving active treatment in the context of a pandemic: An Andalusian cohort study21
Breast cancer care: Looking for the new normal20
Current and prospective antibody-based therapies in multiple myeloma19
A narrative review of the principal glucocorticoids employed in cancer19
Communication strategies during the COVID-19 pandemic: Unforeseen opportunities and drawbacks17
Seminars in oncology 50th anniversary15
Masthead13
Lung Cancer Screening and Precision Oncology13
Airway disorders associated with immune checkpoint inhibitor therapy: Two case reports and a systematic review12
Successful restoration of checkpoint inhibitors efficacy after allogeneic hematopoietic cell transplant for classic Hodgkin lymphoma patients12
TOC12
The likelihood of being helped or harmed obtained from clinical trial results for cancer therapy: Can it really help?12
Editorial Board10
Pioneering the Future of Oncology: A New Vision for Seminars in Oncology9
Assessing Outcomes in NSCLC: Radiomic analysis, kinetic analysis and circulating tumor DNA9
Primary adrenal insufficiency induced by immune checkpoint inhibitors: biological, clinical, and radiological aspects8
Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysis.8
Hepatitis B Virus Reactivation in Cancer Patients Receiving Chemotherapy—A Systematic Review and Meta-Analysis8
Can locally developed me-too drugs aid price negotiation? An example of cancer therapies from China8
Isolated lung metastases from pancreatic ductal adenocarcinoma (PDAC): Diagnostic and therapeutic challenges of a different disease8
Battling chronic myeloid leukemia in a resource-constrained country: A case of public-private partnerships7
High tumor mutation burden mitigates the negative impact of chemotherapy history on immune checkpoint blockade therapy7
Editorial Board7
Plant polyphenols in gastric cancer: Nature's healing touch7
outside front cover6
Improving the efficacy of immunotherapy in small cell lung cancer: Leveraging recent scientific discoveries and tumor-specific antigens6
Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review6
outside front cover6
outside front cover6
CAR T-cell therapy: A collaboration between authorized treatment centers and community oncologists5
Outside front cover5
Editorial Board5
Cancer-specific mortality in patients with non-metastatic renal cell carcinoma who have undergone a nephrectomy and are eligible for adjuvant pembrolizumab5
Masthead5
Efficacy of memantine in preventing neurocognitive dysfunction induced by radiation therapy in patients with brain metastases: A systematic review of clinical trials5
Masthead5
Editorial Board5
COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature5
Challenges in initiating a lung cancer screening program: Experiences from two VA medical centers5
NTRK fusion-positive cancer in nonagenarian patient. The importance of comprehensive geriatric assessment in older people for the inclusion in clinical trials5
From doctors to ancillary staff: Regional and metropolitan cancer workforce perceptions and distress resulting from COVID-19 pandemic adaptations5
Lung cancer screening at the VA: Past, present and future5
Outside front cover4
Torticollis as a presenting symptom of pediatric CNS tumors: A systematic review4
Impact of CT screening in lung cancer: Scientific evidence and literature review4
Deciphering the US Regulatory Framework: Comparison Between Oncology Biosimilars and Reference Biologics4
The heterogeneity of Epithelioid Hemangioendothelioma (EHE): A case series and review of the literature with emphasis on treatment options4
Efficacy of metformin drug in preventing metabolic syndrome associated with androgen deprivation therapy (ADT) in prostate cancer patients: A systematic review and meta-analysis4
Role of neoadjuvant pembrolizumab in advanced melanoma4
Table of Contents4
0.081645965576172